Kynurenine Reduces Memory CD4 T-Cell Survival by Interfering with Interleukin-2 Signaling Early during HIV-1 Infection
- 1 September 2016
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 90 (17) , 7967-7979
Abstract
Early HIV-1 infection is characterized by enhanced tryptophan catabolism, which contributes to immune suppression and disease progression. However, the mechanism by which kynurenine, a tryptophan-related metabolite, induces immune suppression remains poorly understood. Herein, we show that the increased production of kynurenine correlates with defective interleukin-2 (IL-2) signaling in memory CD4 T cells from HIV-infected subjects. Defective IL-2 signaling in these subjects, which drives reduced protection from Fas-mediated apoptosis, was also associated with memory CD4 T-cell loss. Treatment of memory CD4 T cells with the concentration of kynurenine found in plasma inhibited IL-2 signaling through the production of reactive oxygen species. We further show that IL-2 signaling in memory CD4 T cells is improved by the antioxidant N -acetylcysteine. Early initiation of antiretroviral therapy restored the IL-2 response in memory CD4 T cells by reducing reactive oxygen species and kynurenine production. The study findings provide a kynurenine-dependent mechanism through IL-2 signaling for reduced CD4 T-cell survival, which can be reversed by early treatment initiation in HIV-1 infection. IMPORTANCE The persistence of functional memory CD4 T cells represents the basis for long-lasting immune protection in individuals after exposure to HIV-1. Unfortunately, primary HIV-1 infection results in the massive loss of these cells within weeks of infection, which is mainly driven by inflammation and massive infection by the virus. These new findings show that the enhanced production of kynurenine, a metabolite related to tryptophan catabolism, also impairs memory CD4 T-cell survival and interferes with IL-2 signaling early during HIV-1 infection.Keywords
Funding Information
- Canadian HIV Cure Enterprise (Team Grant HIG-133050)
- Gouvernement du Canada | Canadian Institutes of Health Research (MOP 103230, CTN 257)
- Fonds de recherche du Québec-Santé
This publication has 70 references indexed in Scilit:
- Loss of memory B cells during chronic HIV infection is driven by Foxo3a- and TRAIL-mediated apoptosisJournal of Clinical Investigation, 2011
- Tryptophan Catabolism by Indoleamine 2,3-Dioxygenase 1 Alters the Balance of T H 17 to Regulatory T Cells in HIV DiseaseScience Translational Medicine, 2010
- Interleukin‐7 Receptor Signaling Is Deficient in CD4+T Cells from HIV‐Infected Persons and Is Inversely Associated with AgingThe Journal of Infectious Diseases, 2009
- Differential Regulation of Indoleamine-2,3-Dioxygenase (IDO) by HIV Type 1 Clade B and C Tat ProteinAIDS Research and Human Retroviruses, 2009
- Aryl hydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cellsProceedings of the National Academy of Sciences, 2008
- Memory CD4 + T-Lymphocyte Loss and Dysfunction during Primary Simian Immunodeficiency Virus InfectionJournal of Virology, 2007
- Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1Blood, 2007
- Convergence of TCR and cytokine signaling leads to FOXO3a phosphorylation and drives the survival of CD4+ central memory T cellsJournal of Experimental Medicine, 2006
- HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cellsBlood, 2006
- Microbial translocation is a cause of systemic immune activation in chronic HIV infectionNature Medicine, 2006